Chemours is at a cyclical low, presenting a buying opportunity ahead of expected 2Q25 revenue growth. Click here to read an ...

With the Emmy Awards just over a month away, the potential winners are starting to sever themselves from the rest of the pack ...

(Nasdaq: DFDV) (the “Company”) the first public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced it has integrated DoubleZero into its validator ...